Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.
Also called NCT05708690
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 132 participants
- Sponsor
- Registry
-
NCT05708690
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Indonesia
- Registry status
- Completed
Technical summary
Registry record NCT05708690. Randomized; triple masking; primary purpose treatment. Start 2022-10-01 (actual); primary completion 2022-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery
- Condition
- Coronary Artery Disease
- Condition
- Valvular Heart Disease
- Condition
- Surgical Blood Loss
- Intervention (Drug)
- Tranexamic Acid 100 MG/ML
- Intervention (Drug)
- normal saline
- Lead sponsor
- Universitas Indonesia
Record details
- Record id
cardio:ct-nct05708690- Content hash
3c602bb825477e0d8de49a5a77b7eb34a5c2e31a66195b0dba8abd8538d100c9